LeapZipBlog: Mike Williams's blog: Intravenous Immunoglobulin (IVIG) Market Perceptions Targeting Industrial Expansion Studied during the Forecast Period, 2018-2025

Intravenous Immunoglobulin (IVIG) Market Perceptions Targeting Industrial Expansion Studied during the Forecast Period, 2018-2025

December 5, 2019 by Mike Williams  

The global intravenous immunoglobulin (IGIV) market was valued at $8,995 million in 2017and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025.

Immunoglobulins (IGs), also referred to as antibodies, are glycoproteins produced by the blood plasma in response to foreign bodies or antigens. They are highly complex entities and are specific in their action. These immunoglobulins are obtained from blood through the process of fractionation and are purified for use in therapeutic and nontherapeutic areas.

Request for Sample Report @ https://www.factomarketinsights.com/sample/228

Increase in prevalence of immunodeficiency and autoimmune diseases such as chronic inflammatory demyelinating polyneuropathy, hypogammaglobulinemia, & others and rise in adoption of immunoglobulin therapies for the treatment of various autoimmune disorders majorly drive the growth of the IVIG market. Furthermore, increase in approval of IVIG drugs from the Food and Drug Administration (FDA), European Medicine Agency (EMA), and other government agencies is expected to accelerate the growth of the IVIG industry. However, stringent government regulations toward the vigorous use of immunoglobulins, inflated cost of therapy, and high risk of side effects associated with the use of immunoglobulin intravenously are anticipated to hamper the market growth. On the contrary, significant investment in healthcare sector is expected to provide lucrative opportunities for the market growth in the near future.

The global intravenous immunoglobulin (IVIG) market is characterized based on application, type, and region. By application, the market is segmented into hypogammaglobulinemia, CIDP, immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, idiopathic thrombocytopenic purpura (ITP), inflammatory myopathies, specific antibody deficiency, Guillain–Barre syndrome, and others. Depending on type, it is classified into IgG, IgA, IgM, IgE, and IgD. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Click to Get Complete Research report with TOC @ https://www.factomarketinsights.com/report/228/intravenous-immunoglobulin-ivig-market-amr

Key Benefits for Intravenous Immunoglobulin Market:

    The report provides an in-depth analysis of the intravenous immunoglobulin market along with the current trends and future estimations to elucidate the imminent investment pockets.

    A comprehensive analysis of the factors that drive and restrict the market growth is provided in this study.

    The report provides a detailed quantitative analysis of the industry from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.

    An extensive analysis of the key segments of the industry helps to understand the trends in the intravenous immunoglobulin market globally.

    Key players and their strategies are provided to understand the competitive outlook of the industry.

Intravenous Immunoglobulin Key Market Segments:

By Application

    Hypogammaglobulinemia
    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
    Primary Immunodeficiency Disease
    Myasthenia Gravis
    Multifocal Motor Neuropathy
    Idiopathic Thrombocytopenic Purpura (ITP)
    Inflammatory Myopathies
    Specific Antibody Deficiency
    Guillain–Barre Syndrome
    Others

By Type

    IgG
    IgA
    IgM
    IgE
    IgD

Get Sample Report for Detailed Insights @ https://www.factomarketinsights.com/sample/228

By Region

    North America
        U.S.
        Canada
        Mexico
    Europe
        UK
        France
        Germany
        Italy
        France
        Austria
        Russia
        Rest of Europe
    Asia-Pacific
        Japan
        China
        India
        Australia
        Rest of Asia-Pacific
    LAMEA
        Brazil
        Argentina
        Turkey
        Saudi Arabia
        Rest of LAMEA

Key Players Profiled

    Baxter international Inc.
    CSL Ltd.
    Grifols, S.A.
    Octapharma AG
    Kedrion Biopharma Inc.
    LFB Group
    Biotest AG
    China Biologics Products, Inc.
    Takeda Pharmaceuticals
    Bayer AG

 About Us

Facto market insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.

Our in-house research experts have a wealth of knowledge in their respective domains. With Facto Market Research, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.

Contact Us

 United States

150 State St.
Suite 301
Albany, NY 12207
United States
Email: info@factomarketinsights.com

Tel: +1 518-300-1215